Hypertension Clinical Trial
Official title:
Is Reduced Blood Pressure a Consequence of Improved Sleep in Veterans With PTSD?
Verified date | August 2014 |
Source | Durham VA Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Sleep disturbance and posttraumatic stress disorder (PTSD) are common conditions in
returning Veterans, and both conditions are known to increase the risk of cardiovascular
disease. Research suggests that those with insomnia are at triple the risk of high blood
pressure as compared to normal sleepers, and that having both insomnia and short sleep
increases this risk to more than five times that of normal sleepers. These research findings
suggest that recently deployed Veterans with insomnia may be at increased risk of developing
high blood pressure, and this possibility is consistent with previous research. Vietnam era
Veterans with combat-related PTSD assessed in 1985 were twice as likely to have died of
early-onset heart disease relative to their non-PTSD counterparts when reassessed in 2000.
Evidence for impaired cardiac function in individuals with PTSD has been demonstrated across
several studies as well. Compared to individuals without PTSD, those with PTSD seem to have
lesser reaction to stress in terms of both heart rate and heart beat pattern. However, there
has been very little research examining the impact of behavioral sleep interventions on
health outcomes, and even fewer that are specific to a PTSD or Veteran population. The
purpose of this study is to determine if treating insomnia results in improved blood
pressure and cardiac function in recently deployed Veterans with PTSD. The findings of this
research will serve as pilot data for a future grant application testing the efficacy of
Cognitive-Behavioral Therapy for Insomnia (CBTI) for reducing cardiovascular risk in
Veterans with PTSD using a full-scale randomized trial design. We are hypothesizing that
improved sleep will be significantly associated with improved blood pressure and increased
heart rate variability (improved autonomic function) in adults receiving CBTI compared to
those in a wait-list control condition.
Status | Terminated |
Enrollment | 19 |
Est. completion date | August 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 65 Years |
Eligibility |
Inclusion Criteria: Eligible Veterans will: 1) provide informed consent; 2) be OEF/OIF/OND
Veterans who were deployed to Iraq/Afghanistan at least once in a war zone; 3) meet
DSM-IV-R criteria for a diagnosis of current PTSD; 4) endorse nightmares at a frequency of
at least one per week; 5) meet DSM-5 diagnostic criteria for Insomnia; and 6) score
greater than 14 on the Insomnia Severity Index. Exclusion Criteria: Ineligible Veterans: 1) score <23 on the Montreal Cognitive Assessment (MoCA) suggesting inadequate cognitive abilities to successfully participate in this research; 2) have received CBT for insomnia in the past; 2) endorse a current diagnosis of sleep apnea; 3) Screen positive for Sleep Apnea on the STOP Questionnaire; 4) meet criteria for Bipolar Disorder (current or lifetime); 5) meet criteria for a Psychotic Disorder (Current); meet criteria for current Alcohol dependence; 6) meet criteria for current Substance Use Disorder or Substance Dependence; and 7) meet criteria for lifetime Substance Dependence. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Durham VA Medical Center | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Durham VA Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Pressure | Change in both systolic and diastolic blood pressure from baseline to both post-intervention and 3 month follow-up. | 3 months | No |
Secondary | Heart Rate Variability | Change in heart rate variability from baseline to both post-intervention and 3 month follow-up. | 3 Months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |